"The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"
Gastric Cancer, Colorectal Cancer
About this trial
This is an interventional supportive care trial for Gastric Cancer focused on measuring gut microbiota, gut barrier integrity, enteral immunonutrition, gastric cancer, colorectal cancer
Eligibility Criteria
Inclusion Criteria:
- age >18 y.o.
- patients with gastric or colorectal cancer
- patients treated in Department of Surgical Oncology, Medical University of Gdańsk
- patients' agreement to take part in this study
Exclusion Criteria:
- age <18 y.o.
- other types of cancer than gastric/colorectal cancer
- the presence of inflammatory bowel disease
- pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Experimental
Active Comparator
gastric cancer patients (immunonutrition)
gastric cancer patients (standard nutrition)
colorectal cancer patients (immunonutrition)
colorectal cancer patients (standard nutrition)
Experimental gastric cancer group will receive Impact Oral Nestlé Health Science/ Cubitan® Nutricia for 10 days.
These patients will receive Nutridrink® Nutricia/ Resource 2.0 Nestlé Health Science for 10 days.
Experimental colorectal cancer group will receive Impact Oral Nestlé Health Science/ Cubitan® Nutricia for 10 days.
These patients will receive Nutridrink® Nutricia/ Resource 2.0 Nestlé Health Science for 10 days.